Table VII.
Donor |
Recipient |
|||||||
---|---|---|---|---|---|---|---|---|
Species | Vaccine | Challenge | Days vaccinated before exposure |
Clinical disease and/or virus recovery after challenge |
Contact began |
Clinical disease and/or virus recovery |
Reference | |
Cattle | O1 BFS 1860 10 μg/dose Aqueous |
Homologous indirect aerosol from 2 donor pigs for 1 h |
21 | 0/3a | 1b | 0/2 | [29] | |
21 | 0/3 | 7 | 0/2 | |||||
21 | 0/3 | 23 | 0/2 | |||||
21 | 0/3 | 1 | 0/2 | |||||
21 | 1/3 | 1 | 0/2 | |||||
21 | 3/3 | 7 | 0/2 | |||||
14 | 0/3 | 1 | 2/2 | |||||
14 | 2/3 | 1 | 0/2 | |||||
7 | 0/3 | 1 | 1/2 | |||||
7 | 3/3 | 1 | 2/2 | |||||
4 | 0/3 | 1 | 2/2 | |||||
4 | 3/3 | 1 | 2/2 | |||||
0 | 12/12 | 1 | 8/8 | |||||
Pigs | C1 Oberbayern 2.9μg/dose Oil |
Homologous indirect aerosol from 3 donor pigs for 4 h |
7 | 0/3 | 1 | 0/2 | [57] | |
5 | 2/3 | 1 | 2/2 | |||||
4 | 2/3 | 1 | 2/2 | |||||
3 | 3/3 | 1 | 2/2 | |||||
2 | 3/3 | 1 | 2/2 | |||||
0 | 2/2 | 1 | 2/2 | |||||
O1 Lausanne 6.1 μg/dose Oil |
Homologous direct contact with 3 pigs for 2 h |
6 | 3/3 | 1 | 2/2 | [7] | ||
5 | 3/3 | 1 | 2/2 | |||||
4 | 3/3 | 1 | 2/2 | |||||
0 | 3/3 | 1 | 2/2 | |||||
Sheep | Asia 1 India 5.25 μg/dose Oil |
Homologous indirect Aerosol from 3 pigs for 4 h |
10 | 2/3 | 1 | 1/2 | [19] | |
6 | 2/3 | 1 | 1/2 | |||||
4 | 0/3 | 1 | 0/2 | |||||
3 | 0/3 | 1 | 1/2 | |||||
0 | 3/3 | 1 | 2/2 | |||||
C1 Oberbayern 1.4 μg/dose Aqueous |
Homologous indirect Aerosol from 3 pigs for 4 h |
11 | 0/3 | 1 | 0/2 | |||
7 | 0/3 | 1 | 0/2 | |||||
5 | 1/3 | 1 | 0/2 | |||||
4 | 0/3 | 1 | 0/2 | |||||
0 | 2/3 | 1 | 2/2 |
Number of animals clinically diseased or from which virus recovered/total number of animals
number of days after vaccinated animals challenged.